W. Anthony Vernon - Jun 4, 2024 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role
Director
Signature
Ovie Onobrakpeya, as attorney in fact for Vernon, W. Anthony
Stock symbol
NVCR
Transactions as of
Jun 4, 2024
Transactions value $
-$23,033
Form type
4
Date filed
6/6/2024, 05:43 PM
Previous filing
Mar 29, 2024
Next filing
Sep 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCR Ordinary Shares Sale -$23K -964 -0.58% $23.89 165K Jun 4, 2024 Direct F1
transaction NVCR Restricted Stock Units Award $0 +4.05K +2.44% $0.00 170K Jun 5, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NVCR Stock Option (Right to Buy) Award $0 +6.23K $0.00 6.23K Jun 5, 2024 Ordinary Shares 6.23K $23.13 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $23.78 USD to $24.00 USD; the price reported above reflects the weighted average sale price.
F2 These restricted stock units are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2025 annual general meeting of shareholders.
F3 Options to buy 6,229 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2025 annual general meeting of shareholders.